Standard Post Market Clinical Follow-up (PMCF) Study WSA @ HZO
NCT ID: NCT06700512
Last Updated: 2025-08-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2024-06-14
2024-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Standard Post Market Clinical Follow-up (PMCF) Study WSA 2025
NCT06986499
Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids
NCT02298452
Self Fitting Hearing Aid Clinical Investigation
NCT05612763
Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System)
NCT02022085
Clinical Investigation Study of Safety and Performance of the Sentio System.
NCT05166265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Evaluation of Study Device followed by Own devices
within subject design: Subjects wear the study devices for 2 weeks followed by wearing their own hearing aids for 2 weeks. Study devices are fitted as per standard-of-care.
Hearing Aid Signia Pure C&G 7IX
Receiver in Canal (RIC) hearing aid, M Receiver
Own Hearing Aid
subjects' own hearing aids, any brand, any model
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hearing Aid Signia Pure C&G 7IX
Receiver in Canal (RIC) hearing aid, M Receiver
Own Hearing Aid
subjects' own hearing aids, any brand, any model
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They should be experienced hearing aid users
* Air-Bone-Gap should be less or equal to 20 dB Hearing Loss (HL).
* Sensorineural HL, mild-to-moderate
* HL corresponding to the fitting range of the hearing aid
* Healthy (outer) ear
* Older than 18 years
* German is mother tongue
* Able to understand the instructions
* Willing to participate in laboratory tests and to wear the hearing aids at home for 2 weeks
* Informed consent
Exclusion Criteria
* Fluctuating or rapidly progressing hearing loss
* "Central" hearing problems
* Limited mobility
* Limited dexterity (in handling the hearing aid)
* Known psychological problems
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
WSAUD A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Vormann, PhD
Role: PRINCIPAL_INVESTIGATOR
Hörzentrum Oldenburg gGmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hörzentrum Oldenburg gGmbH
Oldenburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D00325215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.